Tumors sound the alarmin(s).
Coffelt. Seth B SB; Scandurro. Aline B AB
Key Findings
- LL‑37 is an alarmin that plays a role in immune responses and tumor biology
- Alarmins like LL‑37 can either promote or suppress tumor growth depending on context
- Targeting alarmins may become a future strategy for cancer treatment, but practical methods are not yet defined
Practical Outcomes
- For now, there’s no direct protocol or dosage recommendation for LL‑37 in longevity or performance hacks. If you’re considering peptide supplementation, be aware that LL‑37 could have complex effects on cancer risk, so more research is needed before using it for health optimization.
Summary
The paper says that LL‑37, a natural immune peptide, belongs to a group called alarmins that can affect how cancers start and grow, but it doesn’t give any clear ways to use or avoid it in everyday health plans.
Abstract
Recent evidence suggests that inflammatory molecules play critical roles in the development and progression of numerous tumors. However, one specific group of inflammatory molecules whose importance has been established in host immune responses, termed alarmins, has been largely overlooked in cancer biology. The function of several alarmins-including the defensins, LL-37, and HMGB1-in tumor development, progression, or suppression is discussed here. Taken together, these studies indicate that alarmins represent potential new targets for manipulation in a variety of tumors.
Study Information
pubmed
2008
2008-08-15T00:00:00.000Z
10.1158/0008-5472.can-08-0044